Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal COVID-19 vaccines: From bench to bed
Aqu Alu, Li Chen, Lei Hong, et al.
EBioMedicine (2022) Vol. 76, pp. 103841-103841
Open Access | Times Cited: 208

Showing 1-25 of 208 citing articles:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 937
Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology
Cátia Domingues, Ana Cláudia Paiva‐Santos, Carmen Alvarez‐Lorenzo, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 9994-10041
Closed Access | Times Cited: 119
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
Meera Madhavan, Adam Ritchie, Jeremy Aboagye, et al.
EBioMedicine (2022) Vol. 85, pp. 104298-104298
Open Access | Times Cited: 106
Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
Jingxing Yang, Jen‐Chih Tseng, Guann‐Yi Yu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 423-423
Open Access | Times Cited: 80
Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
Michael W. Russell, Jiří Městecký
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 77
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 75
Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
Bowen Li, Allen Yujie Jiang, Idris Raji, et al.
Nature Biomedical Engineering (2023)
Closed Access | Times Cited: 68
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Vaccines (2023) Vol. 11, Iss. 3, pp. 682-682
Open Access | Times Cited: 59
Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery
Van‐An Duong, Thi‐Thao‐Linh Nguyen, Han‐Joo Maeng
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 207-207
Open Access | Times Cited: 57
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 47
mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 46
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 15
Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 65
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics
Vivek P. Chavda, Shailvi Soni, Lalitkumar K. Vora, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2150-2150
Open Access | Times Cited: 62
Vaccines, adjuvants and key factors for mucosal immune response
Victor Araujo Correa, Amanda Izeli Portilho, Elizabeth De Gaspari
Immunology (2022) Vol. 167, Iss. 2, pp. 124-138
Open Access | Times Cited: 50
Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
Deepta Bhattacharya
Immunity (2022) Vol. 55, Iss. 6, pp. 945-964
Open Access | Times Cited: 47
Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish
Aurora Kraus, Mar Huertas, Laura V. Ellis, et al.
Brain Behavior and Immunity (2022) Vol. 102, pp. 341-359
Open Access | Times Cited: 38
Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein–Barr virus and the gut–brain axis
Kenji Hashimoto
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 4968-4976
Open Access | Times Cited: 34
Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
Júlia Spinardi, Amit Srivastava
Biomedicines (2023) Vol. 11, Iss. 2, pp. 370-370
Open Access | Times Cited: 32
Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection
Béré Diallo, Caitlín Ní Chasaide, Ting Y. Wong, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
Rupsha Fraser, Aurelio Orta‐Resendiz, Alexander Mazein, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 255-267
Open Access | Times Cited: 31
Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
Gabriela Baldeon Vaca, Michelle Meyer, Ana Cadete, et al.
Science Advances (2023) Vol. 9, Iss. 38
Open Access | Times Cited: 31
Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters
Liang Zhang, Yao Jiang, Jinhang He, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Understanding the Roles of Host Defense Peptides in Immune Modulation: From Antimicrobial Action to Potential as Adjuvants
Ju Kim, Byeol-Hee Cho, Yong‐Suk Jang
Journal of Microbiology and Biotechnology (2023) Vol. 33, Iss. 3, pp. 288-298
Open Access | Times Cited: 28
Aluminum-based metal–organic framework nanoparticles as pulmonary vaccine adjuvants
Zachary Stillman, Gerald E. Decker, Michael R. Dworzak, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top